{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:55:11Z","timestamp":1792641311028,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Opportunistic infections (OIs) are common causes of mortality among people living with HIV (PLHIV). We determined prevalence and 30-day mortality due to histoplasmosis, cryptococcosis, and TB in PLHIV with advanced HIV disease (AHD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PLHIV 18 years and older, with a CD4\u2009+\u2009T-cell count of less than 350 cells\/mm3 newly diagnosed with HIV infection or re-engaged in care after being without ART for more than 90 days (Group A). The second group included symptomatic PLHIV regardless of ART status or CD4\u2009+\u2009T-cell count (Group B); all followed for 30 days. Detection of <jats:italic>Histoplasma<\/jats:italic> Ag (HisAg) in urine was done by enzyme immunoassay (EIA), <jats:italic>Cryptococcus<\/jats:italic> antigen (CrAg) was detected in serum and cerebrospinal fluid (CSF) specimens by lateral flow assay (LFA), and lipoarabinomannan (LAM) detection in urine was by LFA (TB LAM) and in sputum by GeneXpert for diagnosis of <jats:italic>Mycobacterium<\/jats:italic> infections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>From August 2021 to June 2022, 491 PLHIV were enrolled; 482 (98%) had a CD4\u2009+\u2009T-cell result, and 381 patients (79%) were classified with AHD according to CD4\u2009+\u2009T-cell count (&lt;\u2009200 CD4\/mm<jats:sup>3<\/jats:sup>). Frequency of an OI was 38% (<jats:italic>n<\/jats:italic>\u2009=\u2009145\/381). Antigen test positivity rate was 16% (72\/467) for TB-LAM, 9% (43\/464) for HisAg, and 11% (51\/484) for CrAg. Twenty-one of 34 (62%) patients receiving CSF CrAg tests were positive, confirming meningitis. Significant differences in 30-day mortality were observed in patients with an OI (16%) vs. no OI (7%) (<jats:italic>p<\/jats:italic>\u2009=\u20090.002). Mortality was highest in patients with histoplasmosis (25%), co-infection (22%), cryptococcosis (18% overall; 19% for cryptococcal meningitis), and TB (10%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>TB and fungal OIs, including co-infection, were common in PLHIV in Paraguay and had high associated mortality. Laboratories and health facilities need access to CD4\u2009+\u2009T-cell testing and rapid diagnostic assays.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09257-5","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T07:03:56Z","timestamp":1713251036000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Implementation of a rapid diagnostic assay package for cryptococcosis, histoplasmosis and tuberculosis in people living with HIV in Paraguay"],"prefix":"10.1186","volume":"24","author":[{"given":"Gloria","family":"Aguilar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gladys","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Sued","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narda","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego H.","family":"Caceres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgilio","family":"Lezcano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Vicenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Benitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Samudio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"9257_CR1","doi-asserted-by":"crossref","unstructured":"Medina N, Alastruey-Izquierdo A, Bonilla O, Gamboa O, Mercado D, P\u00e9rez JC et al. A Rapid Screening Program for Histoplasmosis, Tuberculosis, and Cryptococcosis Reduces Mortality in HIV Patients from Guatemala. J Fungi (Basel) [Internet]. 2021 Apr 1 [cited 2023 Jul 10];7(4). https:\/\/pubmed.ncbi.nlm.nih.gov\/33916153\/.","DOI":"10.3390\/jof7040268"},{"key":"9257_CR2","unstructured":"Ministerio de Salud P\u00fablica y Bienestar Social. Informe Situaci\u00f3n Epidemiol\u00f3gica del VIH Paraguay [Internet]. 2021 [cited 2023 Oct 9]. https:\/\/www.mspbs.gov.py\/dependencias\/pronasida\/adjunto\/5e8632-InformeEpidemiolgicoVIH2021.pdf."},{"key":"9257_CR3","unstructured":"World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. Behaviour and Information Technology [Internet]. 2017 [cited 2023 Jul 3];2(2):127\u201361. https:\/\/www.who.int\/publications\/i\/item\/9789241550062."},{"key":"9257_CR4","doi-asserted-by":"crossref","unstructured":"Adenis A, Nacher M, Hanf M, Basurko C, Dufour J, Huber F et al. Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study. Am J Trop Med Hyg [Internet]. 2014 Feb [cited 2023 Jul 3];90(2):216\u201323. https:\/\/pubmed.ncbi.nlm.nih.gov\/24394475\/.","DOI":"10.4269\/ajtmh.13-0084"},{"key":"9257_CR5","doi-asserted-by":"crossref","unstructured":"Rajasingham R, Govender NP, Jordan A, Loyse A, Shroufi A, Denning DW et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis [Internet]. 2022 Dec 1 [cited 2023 Jul 3];22(12):1748\u201355. https:\/\/pubmed.ncbi.nlm.nih.gov\/36049486\/.","DOI":"10.1016\/S1473-3099(22)00499-6"},{"key":"9257_CR6","unstructured":"World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV [Internet]. 2022 [cited 2023 Jul 3]. Available from: Guidelines for Diagnosing preventing and managing cryptococcal disease among adults adolescents and children living with HIV."},{"key":"9257_CR7","doi-asserted-by":"crossref","unstructured":"Samayoa B, Roy M, Cleveland AA. High Mortality and Coinfection in a Prospective Cohort of Human Immunodeficiency Virus\/Acquired Immune Deficiency Syndrome Patients with Histoplasmosis in Guatemala. Am J Trop Med Hyg. 2017;2017;97(1):42\u201348.","DOI":"10.4269\/ajtmh.16-0009"},{"key":"9257_CR8","doi-asserted-by":"crossref","unstructured":"Caceres DH, Valdes A. Histoplasmosis and Tuberculosis Co-Occurrence in People with Advanced HIV. J Fungi (Basel) [Internet]. 2019 Sep 1 [cited 2023 Jul 3];5(3). https:\/\/pubmed.ncbi.nlm.nih.gov\/31404979\/.","DOI":"10.3390\/jof5030073"},{"key":"9257_CR9","doi-asserted-by":"crossref","unstructured":"Rajasingham R, Wake RM, Beyene T, Katende A, Letang E, Boulware DR. Cryptococcal Meningitis Diagnostics and Screening in the Era of Point-of-Care Laboratory Testing. J Clin Microbiol [Internet]. 2019 Jan 1 [cited 2023 Jul 3];57(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/30257903\/.","DOI":"10.1128\/JCM.01238-18"},{"key":"9257_CR10","doi-asserted-by":"crossref","unstructured":"Azar MM, Hage CA. Laboratory Diagnostics for Histoplasmosis. J Clin Microbiol [Internet]. 2017 Jun 1 [cited 2023 Jul 3];55(6):1612\u201320. https:\/\/pubmed.ncbi.nlm.nih.gov\/28275076\/.","DOI":"10.1128\/JCM.02430-16"},{"key":"9257_CR11","doi-asserted-by":"crossref","unstructured":"Caceres DH, Valdes A. Histoplasmosis and Tuberculosis Co-Occurrence in People with Advanced HIV. J Fungi (Basel) [Internet]. 2019 Sep 1 [cited 2023 Jul 11];5(3). https:\/\/pubmed.ncbi.nlm.nih.gov\/31404979\/.","DOI":"10.3390\/jof5030073"},{"key":"9257_CR12","unstructured":"Ministerio de Salud P\u00fablica y Bienestar Social. Situaci\u00f3n, epidemiol\u00f3gica de la tuberculosis en paraguay. 2019\u20132022 [Internet]. [cited 2023 Oct 9]. https:\/\/dgvs.mspbs.gov.py\/wp-content\/uploads\/2023\/08\/1INFORME-ESPECIAL-TUBERCULOSIS_DGVS_MSPBS_2019_2022.pdf."},{"key":"9257_CR13","doi-asserted-by":"crossref","unstructured":"Medina N, Alastruey-Izquierdo A, Bonilla O, Gamboa O, Mercado D, P\u00e9rez JC et al. A Rapid Screening Program for Histoplasmosis, Tuberculosis, and Cryptococcosis Reduces Mortality in HIV Patients from Guatemala. J Fungi (Basel) [Internet]. 2021 Apr 1 [cited 2023 Jul 3];7(4). https:\/\/pubmed.ncbi.nlm.nih.gov\/33916153\/.","DOI":"10.3390\/jof7040268"},{"key":"9257_CR14","doi-asserted-by":"crossref","unstructured":"Wake RM, Britz E, Sriruttan C, Rukasha I, Omar T, Spencer DC et al. High Cryptococcal Antigen Titers in Blood Are Predictive of Subclinical Cryptococcal Meningitis Among Human Immunodeficiency Virus-Infected Patients. Clin Infect Dis [Internet]. 2018 Mar 1 [cited 2023 Jul 3];66(5):686\u201392. https:\/\/pubmed.ncbi.nlm.nih.gov\/29028998\/.","DOI":"10.1093\/cid\/cix872"},{"key":"9257_CR15","volume-title":"Disseminated histoplasmosis (DH) before and after the implementation of urine Antigen Detection Elisa (UADE) in an HIV clinic in Guatemala","author":"B Samoya","year":"2012","unstructured":"Samoya B, Mercado E, Argueta D, Scheel C, Guzman B, Amado I, et al. Disseminated histoplasmosis (DH) before and after the implementation of urine Antigen Detection Elisa (UADE) in an HIV clinic in Guatemala. San Francisco: ICCAC; 2012."},{"key":"9257_CR16","doi-asserted-by":"crossref","unstructured":"Adenis A, Nacher M, Hanf M, Vantilcke V, Boukhari R, Blachet D et al. HIV-Associated Histoplasmosis Early Mortality and Incidence Trends: From Neglect to Priority. PLoS Negl Trop Dis [Internet]. 2014 Aug 21 [cited 2023 Jul 3];8(8):e3100. https:\/\/journals.plos.org\/plosntds\/article?id=10.1371\/journal.pntd.0003100.","DOI":"10.1371\/journal.pntd.0003100"},{"key":"9257_CR17","doi-asserted-by":"crossref","unstructured":"Kanyama C, Chagomerana MB, Chawinga C, Ngoma J, Shumba I, Kumwenda W et al. Implementation of tuberculosis and cryptococcal meningitis rapid diagnostic tests amongst patients with advanced HIV at Kamuzu Central Hospital, Malawi, 2016\u20132017. BMC Infect Dis [Internet]. 2022 Dec 1 [cited 2023 Jul 3];22(1). https:\/\/pubmed.ncbi.nlm.nih.gov\/35247971\/.","DOI":"10.1186\/s12879-022-07224-6"},{"key":"9257_CR18","unstructured":"Mor\u00ednigo C, Mar\u00eda D, Bar\u00e1n T, \u00c1gueda D, Sarubbi C, Sarita D et al. Gu\u00eda Nacional para el manejo de la Tuberculosis Autoridades."},{"key":"9257_CR19","doi-asserted-by":"crossref","unstructured":"Lee SW. Methods for testing statistical differences between groups in medical research: statistical standard and guideline of Life Cycle Committee. Life Cycle. 2022;2.","DOI":"10.54724\/lc.2022.e1"},{"key":"9257_CR20","unstructured":"World Health Organization. Lateral Flow urine Lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV Policy update [Internet]. Vol. 2019. 2019 [cited 2023 Jul 3]. https:\/\/apps.who.int\/iris\/handle\/10665\/329479."},{"key":"9257_CR21","doi-asserted-by":"crossref","unstructured":"Rajasingham R, Medina N, Mousquer GT, Caceres DH, Jordan A, Nacher M et al. Cost-effectiveness evaluation of routine histoplasmosis screening among people living with advanced HIV disease in Latin America and the Caribbean. PLOS global public health [Internet]. 2023 Aug 15 [cited 2024 Jan 6];3(8):e0001861. https:\/\/pubmed.ncbi.nlm.nih.gov\/37582115\/.","DOI":"10.1371\/journal.pgph.0001861"},{"key":"9257_CR22","doi-asserted-by":"crossref","unstructured":"Ferreira M, de Brito-Santos F, Trilles F, Almeida L, Wanke MA, Veloso B. VG, Cryptococcal antigenemia prevalence and clinical data in HIV-infected patients from the reference centre at INI-FIOCRUZ, Rio de Janeiro, Southeast of Brazil. Mycoses [Internet]. 2020 Feb 1 [cited 2023 Jul 3];63(2):145\u201350. https:\/\/pubmed.ncbi.nlm.nih.gov\/31715053\/.","DOI":"10.1111\/myc.13032"},{"key":"9257_CR23","doi-asserted-by":"crossref","unstructured":"Jarvis JN, Harrison TS, Lawn SD, Meintjes G, Wood R, Cleary S. Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa. PLoS One [Internet]. 2013 Jul 19 [cited 2023 Jul 3];8(7):e69288. https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0069288.","DOI":"10.1371\/journal.pone.0069288"},{"key":"9257_CR24","doi-asserted-by":"crossref","unstructured":"Cano-Torres JO, Olmedo-Reneaum A, Esquivel-S\u00e1nchez JM, Camiro-Zu\u00f1iga A, P\u00e9rez-Carrisoza A, Madrigal-Iberri C et al. Progressive disseminated histoplasmosis in Latin America and the Caribbean in people receiving highly active antiretroviral therapy for HIV infection: A systematic review. Med Mycol [Internet]. 2019 Oct 1 [cited 2023 Jul 3];57(7):791\u20139. https:\/\/pubmed.ncbi.nlm.nih.gov\/30668766\/.","DOI":"10.1093\/mmy\/myy143"},{"key":"9257_CR25","doi-asserted-by":"crossref","unstructured":"Boigues BCS, Paniago AMM, Lima GME, Nunes M, de de O, Uehara SN. O. Clinical outcomes and risk factors for death from disseminated histoplasmosis in patients with AIDS who visited a high-complexity hospital in Campo Grande, MS, Brazil. Rev Soc Bras Med Trop [Internet]. 2018 Mar 1 [cited 2023 Jul 3];51(2):155\u201361. https:\/\/pubmed.ncbi.nlm.nih.gov\/29768547\/.","DOI":"10.1590\/0037-8682-0369-2017"},{"key":"9257_CR26","doi-asserted-by":"crossref","unstructured":"Nacher M, Leitao TS, G\u00f3mez BL, Couppi\u00e9 P, Adenis A, Damasceno L et al. The Fight against HIV-Associated Disseminated Histoplasmosis in the Americas: Unfolding the Different Stories of Four Centers. Journal of Fungi 2019, Vol 5, Page 51 [Internet]. 2019 Jun 17 [cited 2023 Jul 3];5(2):51. https:\/\/www.mdpi.com\/2309-608X\/5\/2\/51\/htm.","DOI":"10.3390\/jof5020051"},{"key":"9257_CR27","doi-asserted-by":"crossref","unstructured":"Bongomin F, Kwizera R, Denning DW. Getting Histoplasmosis on the Map of International Recommendations for Patients with Advanced HIV Disease. Journal of Fungi [Internet]. 2019 Sep 1 [cited 2023 Jul 3];5(3). \/pmc\/articles\/PMC6787619\/.","DOI":"10.3390\/jof5030080"},{"key":"9257_CR28","doi-asserted-by":"crossref","unstructured":"Basso RP, Poester VR, Benelli JL, Stevens DA, Xavier MO. Disseminated Histoplasmosis in Persons with HIV\/AIDS, Southern Brazil, 2010\u20132019. Emerg Infect Dis [Internet]. 2022 Mar 1 [cited 2023 Nov 12];28(3):721. \/pmc\/articles\/PMC8888216\/.","DOI":"10.3201\/eid2803.212150"},{"key":"9257_CR29","doi-asserted-by":"crossref","unstructured":"Falci DR, Monteiro AA, Braz Caurio CF, Magalh\u00e3es TCO, Xavier MO, Basso RP et al. Histoplasmosis, An Underdiagnosed Disease Affecting People Living With HIV\/AIDS in Brazil: Results of a Multicenter Prospective Cohort Study Using Both Classical Mycology Tests and Histoplasma Urine Antigen Detection. Open Forum Infect Dis [Internet]. 2019 Apr 13 [cited 2023 Jul 10];6(4). https:\/\/pubmed.ncbi.nlm.nih.gov\/30997365\/.","DOI":"10.1093\/ofid\/ofz073"},{"key":"9257_CR30","doi-asserted-by":"crossref","unstructured":"C\u00e1ceres DH, G\u00f3mez BL, Tob\u00f3n \u00c1M, Restrepo \u00c1, Chiller T, Lindsley MD et al. Tackling Histoplasmosis Infection in People Living with HIV from Latin America: From Diagnostic Strategy to Public Health Solutions. Journal of Fungi [Internet]. 2023 May 1 [cited 2023 Jul 3];9(5). \/pmc\/articles\/PMC10218911\/.","DOI":"10.3390\/jof9050558"},{"key":"9257_CR31","doi-asserted-by":"crossref","unstructured":"Esmail A, Pooran A, Sabur NF, Fadul M, Brar MS, Oelofse S et al. An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB\/RIF and Alere Determine TB LAM Ag. J Clin Microbiol [Internet]. 2020 Oct 1 [cited 2023 Jul 3];58(10). https:\/\/pubmed.ncbi.nlm.nih.gov\/32727831\/.","DOI":"10.1128\/JCM.01032-20"},{"key":"9257_CR32","doi-asserted-by":"crossref","unstructured":"Belaunzar\u00e1n-Zamudio PF, Caro-Vega YN, Shepherd BE, Rebeiro PF, Crabtree-Ram\u00edrez BE, Cortes CP et al. The Population Impact of Late Presentation With Advanced HIV Disease and Delayed Antiretroviral Therapy in Adults Receiving HIV Care in Latin America. Am J Epidemiol [Internet]. 2020 Jun 1 [cited 2023 Jul 3];189(6):564\u201372. https:\/\/pubmed.ncbi.nlm.nih.gov\/31667488\/.","DOI":"10.1093\/aje\/kwz252"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09257-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09257-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T07:05:49Z","timestamp":1713251149000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09257-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9257"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09257-5","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,16]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Signed written informed consent was sought from each patient before performing any procedure.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"406"}}